185 results on '"Fuggle, S. V."'
Search Results
2. Using an Integrated -Omics Approach to Identify Key Cellular Processes That Are Disturbed in the Kidney After Brain Death
3. Access to kidney transplantation for highly sensitised patients (HSPs): O11
4. Development of de novo HLA antibodies following islet transplant alone: O14
5. High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms
6. The UK Pancreas Allocation Scheme for Whole Organ and Islet Transplantation
7. Genetic Variation in Caveolin-1 Correlates With Long-Term Pancreas Transplant Function
8. Should HLA Mismatch Acceptability for Sensitized Transplant Candidates Be Determined at the High-Resolution Rather Than the Antigen Level?
9. De Novo Donor-Specific HLA Antibodies: Biomarkers of Pancreas Transplant Failure
10. Alemtuzumab and Sirolimus in Renal Transplantation: Six-Year Results of a Single-Arm Prospective Pilot Study
11. Pancreas Transplantation From Donors After Circulatory Death From the United Kingdom
12. Pancreas Transplantation From Donors After Circulatory Death From the United Kingdom
13. British Society for Histocompatibility & Immunogenetics and British Transplantation Society Guidelines for the Detection and Characterisation of Clinically Relevant Antibodies in Allotransplantation
14. Development of a robust first line HLA antibody screening strategy: 1.51
15. Renal transplantation for patients from ethnic minorities in the UK: P-219
16. A new national scheme for allocation of deceased heartbeating donor kidneys in the UK: P-218
17. The identification of three novel MICA alleles by sequence-based typing
18. A novel major histocompatibility complex class I-related chain allele
19. Identification of a novel MICA allele: MICA*051
20. Human platelet alloantigens (HPAs): PCR-SSP genotyping of a UK population for 15 HPA alleles
21. Comprehensive hereditary hemochromatosis genotyping
22. Characterization of a novel HLA-C allele, Cw*0315
23. IS HLA MATCHING NECESSARY IN LIVING DONOR KIDNEY TRANSPLANTATION?
24. LABORATORY PRACTICE IN ANTIBODY SCREENING AND CROSSMATCHING FOR RENAL TRANSPLANTATION
25. Identification of an HLA-B7 serological variant and its characterization by sequencing based typing
26. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation
27. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation
28. Identification of an HLA-A11 serological variant and its characterization by sequencing based typing
29. Identification of an HLA-C variant allele, Cw*0805, by sequencing based typing
30. CROSS-SPECIES REACTIVITY OF THE MYELOID PANEL OF ANTIBODIES: MC-5-13
31. VASCULAR HETEROGENEITY DETECTED BY THE ENDOTHELIAL CELL PANEL ANTIBODIES: EC-1-09
32. CROSS-REACTIVITY OF THE ADHESION PANEL ANTIBODIES WITH CYNOMOLGOUS MONKEY AND PORCINE TISSUE: AS-5-02
33. HLA in Transplantation
34. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients: Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity
35. Monoclonal Antibody Definition of Polymorphism Within DRw52
36. Definition of Polymorphism Within DR2-Associated DQw1 Molecules
37. BENEFICIAL EFFECT OF PRESERVATION BY MACHINE PERFUSION ON POSTOPERATIVE OUTCOME OF KIDNEYS FROM CONTROLLED DONORS AFTER CARDIAC DEATH
38. PANCREAS TRANSPLANTATION: TRANSPLANTING SENSITISED PATIENTS IN THE UK
39. PAIRED LIVING KIDNEY DONATION IN THE UK
40. OUTCOMES OF KIDNEYS DONATED AFTER CARDIAC DEATH
41. UK REGISTRY OF ANTIBODY INCOMPATIBLE KIDNEY TRANSPLANTATION 2001–2010
42. ANTIBODIES TO ALLOGENEIC AND AUTOLOGOUS ENDOTHELIAL PRECURSOR CELLS DETECTED BY XM-ONE ASSAY: ANALYSIS IN LIVING DONOR RENAL TRANSPLANTS
43. IMPACT OF THE 2006 UK NATIONAL KIDNEY ALLOCATION SCHEME
44. RENAL TRANSPLANTATION IN SENSITISED PATIENTS: HLA MATCHING REDUCES INCIDENCEOF EARLY GRAFT FAILURE
45. THE IMMUNOGENICITY OF HLA DETERMINED AT THE STRUCTURAL AND PHYSIOCHEMICAL LEVEL PREDICTS THE OCCURRENCE AND MAGNITUDE OF HUMORAL IMMUNE RESPONSES TO ALLOANTIGEN AND CORRELATES WITH OUTCOME FOLLOWING DECEASED DONOR KIDNEY TRANSPLANTATION
46. PANCREAS TRANSPLANTATION: A UK AND US COMPARISON
47. A positive B cell crossmatch due to IgG anti-HLA-DQ antibody present at the time of transplantation in a successful renal allograft
48. NON-HEART BEATING VERSUS CADAVERIC LIVER TRANSPLANTATION: DIFFERENCES IN INFLAMMATORY MARKERS FOLLOWING REPERFUSION
49. ISCHAEMIC PRECONDITIONING TO CADAVER DONOR LIVERS PROTECTS ALLOGRAFTS AND REDUCES INFLAMMATORY CHANGES AFTER REPERFUSION
50. SHORT-TERM TRANSPLANT SURVIVAL OF LIVING DONOR KIDNEY TRANSPLANTS IN THE UK
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.